FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib
Clinical trial NCT01143779 · COMPLETED
Trial details
- NCT number
- NCT01143779
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2021-12-27
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.